Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs

SHANGHAI, Dec. 14, 2023 /PRNewswire/ -- The Japan-based Global Health Innovative Technology Fund announced today that it will invest approximately US$3.3 million in a global multicenter Phase III...

Related Keywords

Japan ,Vietnam ,Republic Of ,Cambodia ,Shanghai ,China ,Thailand ,Rwanda ,Uganda ,Chinese ,Japanese ,Fosun Pharma ,Wen Deyong ,Osamu Kunii ,Melinda Gates Foundation ,Global Health Innovative Technology Fund ,China Most Admired Company List ,Sinopharm Co Ltd ,United Nations Development Programme ,World Health Organization ,Seasonal Malaria Chemoprevention Program ,Mahidol Oxford Tropical Medicine Research Unit ,Wellcome ,Southeast Asia ,Malaria Venture ,Greater Mekong Subregion ,Sub Saharan Africa ,Most Admired Company ,Malaria Prevention Knowledge Popularization ,Malaria Chemoprevention ,Shanghai Fosun Pharmaceutical ,Integrated Operation ,Lao People ,Democratic Republic ,Yunnan Province ,Guangxi Zhuang Autonomous Region ,Markets ,